Trombose de veia porta em 33 cães / Portal vein thrombosis in 33 dogs

Standard Article

You have full text access to this content

Portal Vein Thrombosis in 33 Dogs: 1998–2011

1. M. Respess^1,*, 
2. T.E. O'Toole¹, 
3. O. Taeymans¹, 
4. C.L. Rogers², 
5. A. Johnston¹,
6. C.R.L. Webster¹

Article first published online: 28 FEB 2012

DOI: 10.1111/j.1939-1676.2012.00893.x

Copyright © 2012 by the American College of Veterinary Internal Medicine

Issue

Journal of Veterinary Internal Medicine

Volume 26, Issue 2, pages 230–237, March-April 2012

Additional Information(Show All)

Keywords:

• Coagulation;
• Coagulopathy;
• Liver disease;
• Thromboembolism

Background

Portal vein thrombosis (PVT) has been reported infrequently in dogs.

Objectives

To characterize the presentation, associated disease conditions, and outcome in dogs with PVT.

Animals

Client-owned dogs with a diagnosis of PVT and a complete medical record.

Methods

Records were retrospectively analyzed for presentation, history, physical examination, clinicopathologic data, diagnostic imaging, treatment, and outcome.

Results

Thirty-three dogs were included. Common clinical signs were vomiting, diarrhea, abdominal pain, ascites, and signs of hypovolemic shock. Associated disease conditions included hepatic (14/33), neoplastic (7/33), immune (5/33), and infectious (4/33) diseases, protein-losing nephropathy (3/33), hyperadrenocorticism (2/33), protein-losing enteropathy (1/33), and pancreatitis (1/33). Fourteen dogs were receiving glucocorticoids at the time of diagnosis. Twenty-nine dogs had at least 1 predisposing condition for venous thrombosis, and 11 had 2 or more. Thrombocytopenia (24/33), increased liver enzyme activity (23/33), and hypoalbuminemia (20/33) were common laboratory abnormalities. Clinical syndromes at the time of PVT diagnosis included shock (16/33), systemic inflammatory response syndrome (SIRS), (13/33) and disseminated intravascular coagulation (3/33). Twenty-four dogs had acute and 9 had chronic PVT. Multiple thrombi were found in 17/33 dogs. Nineteen dogs survived to discharge. Dogs treated with anticoagulant therapy were more likely, whereas those with acute PVT, multiple thromboses or SIRS were less likely to survive.

Conclusions and Clinical Importance

Hepatic disease is a common pre-existing condition in dogs with PVT. PVT should be considered in dogs with risk factors for venous thrombosis presenting with abdominal pain, ascites, and thrombocytopenia. Studies evaluating anticoagulant therapy in the management of PVT are warranted.